Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers. 

Biotechnology

Rigel Pharmaceuticals

Rigel Pharmaceuticals' headquarters in South San Francisco, CA, United States

Raul R. Rodriguez

Julie Patel

Dean Schorno

Lisa Rojkjaer

David Santos

Elliot Grossbard

Heather Beaudoin

Mike Morrow

Ray Furey

Esteban Masuda

Gregg Lapointe

Walter H. Moos

Brian Kotzin

Gretchen Kramer

Jane Wasman

Kamil Ali-Jackson

Alison L. Hannah

This department focuses on overseeing and driving sales activities across various territories.

Sales Management

The Sales and Marketing team at Rigel Pharmaceuticals is responsible for driving the commercial success of the company’s innovative therapies. This team develops strategic marketing plans, engages with healthcare professionals, and manages relationships with key accounts to ensure access to Rigel's drugs. By leveraging market insights and collaborating closely with cross-functional teams, they aim to effectively communicate the value of Rigel's products in treating immune diseases and cancers, ultimately enhancing patient access and improving outcomes.

Sales and Marketing

The Finance and Accounting team at Rigel Pharmaceuticals oversees the company’s financial operations, ensuring accurate financial reporting, compliance with regulations, and effective budget management. They manage payroll, oversee revenue recognition, and support business development initiatives through strategic financial planning and analysis. This team plays a crucial role in maintaining the financial health of the organization while facilitating the funding of innovative drug development.

Finance and Accounting

The Medical Affairs team at Rigel Pharmaceuticals is responsible for bridging the gap between clinical research and market access by providing scientific and medical expertise. They engage with healthcare professionals and institutions to communicate data on Rigel's innovative therapies, support clinical education, and ensure that patients have access to the company's groundbreaking treatments. Additionally, they play a critical role in shaping the strategic direction of medical programs and fostering relationships with key opinion leaders in the field.

Medical Affairs

The Research and Development team at Rigel Pharmaceuticals is dedicated to the discovery and advancement of innovative small-molecule therapies targeting immune diseases and cancers. This multidisciplinary group collaborates on drug design, preclinical and clinical research, regulatory affairs, and medical communications, working to translate scientific discoveries into impactful treatments that improve patient outcomes.

Research and Development

The Leadership Team at Rigel Pharmaceuticals is responsible for guiding the company's strategic direction, overseeing operational execution, and fostering collaboration across departments. This team, comprising executives from various functions such as finance, research, business development, and human resources, ensures alignment with the company’s goals in developing innovative therapies for immune diseases and cancers while navigating the complexities of the biotechnology industry. Their leadership and decision-making are pivotal for advancing Rigel’s clinical programs and maximizing growth opportunities.

Rigel Pharmaceuticals

Org chart

Board & advisors

Teams

Sales Management

Sales and Marketing

Finance and Accounting

Medical Affairs

Research and Development

Leadership Team

Offices

Rigel Pharmaceuticals

Org chart

Board & advisors

Teams

Sales Management

Sales and Marketing

Finance and Accounting

Medical Affairs

Research and Development

Leadership Team

Offices

Related companies